A More COMPLETE Picture of Revascularization in STEMI

Up to half of patients presenting with acute ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease, and American College of Cardiology–American Heart Association–European Society of Cardiology guidelines have a class IIb recommendation for the treatment of noncu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine Jg. 381; H. 15; S. 1472 - 1474
Hauptverfasser: Køber, Lars, Engstrøm, Thomas
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Massachusetts Medical Society 10.10.2019
Schlagworte:
Cardiology
Cardiovascular disease
Clinical trials
Coronary artery
Coronary vessels
Heart attacks
Heart diseases
Humans
Mortality
Myocardial Infarction
Myocardial Revascularization
Percutaneous Coronary Intervention
ST Elevation Myocardial Infarction
Stents
ISSN:0028-4793, 1533-4406, 1533-4406
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Up to half of patients presenting with acute ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease, and American College of Cardiology–American Heart Association–European Society of Cardiology guidelines have a class IIb recommendation for the treatment of nonculprit lesions. 1-4 Four intermediate-sized trials have shown that complete revascularization is safe and reduces the risk of repeat revascularization. 5-8 Until now, a general strategy of complete revascularization has not been shown to reduce the risk of hard outcomes, such as death and recurrent myocardial infarction. In addition, it has been suggested that identification of nonculprit lesions relevant for complete revascularization should be . . . Lars Køber and Thomas Engstrøm comment on the findings of the COMPLETE trial and their implications for the use of complete revascularization in patients with STEMI and multivessel disease.
Bibliographie:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMe1910898